Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · IEX Real-Time Price · USD

36.76

-0.81 (-2.16%)

At close: Jul 19, 2024, 4:00 PM

36.77

+0.01 (0.03%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Celldex Therapeutics Market Cap

Celldex Therapeutics has a market cap or net worth of $2.42 billion as of July 22, 2024. Its market cap has increased by 44.56% in one year.

Market Cap

2.42B

Enterprise Value

1.60B

1-Year Change

44.56%

Ranking

#1804

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $2.42B, an increase of 1,535.97%. That is a compound annual growth rate of 14.23%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	2.42B	29.26%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	237.20%
Dec 31, 2007	37.10M	-62.68%
Dec 29, 2006	99.40M	-28.69%
Dec 30, 2005	139.40M	-6.44%
Dec 31, 2004	149.00M	-15.96%
Dec 31, 2003	177.30M	19.72%

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Astrana Health	2.52B
PTC Therapeutics	2.50B
Ardent Health Partners	2.48B
Integra LifeSciences Holdings	2.47B
Vericel	2.44B
Intellia Therapeutics	2.42B
UFP Technologies	2.40B
Myriad Genetics	2.35B

Market Cap Rankings